Table 2 Proportion of patient-days with exposure to time-varying covariates
Time-varying exposure | Percentage of days of follow-up with exposure |
|---|---|
Trimethoprim-sulfamethoxazole | 24.7 % |
Azithromycin | 12.0 % |
HAART | 77.1 % |
Catheter | 1.6 % |
Public Aid | 79.8 % |
Viral load | |
<1000 copies/mL | 60.0 % |
1000+ copes/mL | 40.0 % |
CD4 | |
<50 cells/mL | 6.5 % |
50–99 cells/mL | 4.0 % |
100+ cells/mL | 89.5 % |
Cancer | 7.8 % |
Diabetes | 14.6 % |
End-stage renal disease | 11.5 % |